Loading…

A predictive scoring instrument for tuberculosis lost to follow-up outcome

Adherence to tuberculosis (TB) treatment is troublesome, due to long therapy duration, quick therapeutic response which allows the patient to disregard about the rest of their treatment and the lack of motivation on behalf of the patient for improved. The objective of this study was to develop and v...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory research 2012-09, Vol.13 (1), p.75-75
Main Authors: Rodrigo, Teresa, Caylà, Joan A, Casals, Martí, García-García, José M, Caminero, José A, Ruiz-Manzano, Juan, Blanquer, Rafael, Vidal, Rafael, Altet, Neus, Calpe, José L, Penas, Antón
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b646t-bea21475a782c0445a94f137dc418dd60913a6cc22a210cf41ab0ed24fe6844a3
cites cdi_FETCH-LOGICAL-b646t-bea21475a782c0445a94f137dc418dd60913a6cc22a210cf41ab0ed24fe6844a3
container_end_page 75
container_issue 1
container_start_page 75
container_title Respiratory research
container_volume 13
creator Rodrigo, Teresa
Caylà, Joan A
Casals, Martí
García-García, José M
Caminero, José A
Ruiz-Manzano, Juan
Blanquer, Rafael
Vidal, Rafael
Altet, Neus
Calpe, José L
Penas, Antón
description Adherence to tuberculosis (TB) treatment is troublesome, due to long therapy duration, quick therapeutic response which allows the patient to disregard about the rest of their treatment and the lack of motivation on behalf of the patient for improved. The objective of this study was to develop and validate a scoring system to predict the probability of lost to follow-up outcome in TB patients as a way to identify patients suitable for directly observed treatments (DOT) and other interventions to improve adherence. Two prospective cohorts, were used to develop and validate a logistic regression model. A scoring system was constructed, based on the coefficients of factors associated with a lost to follow-up outcome. The probability of lost to follow-up outcome associated with each score was calculated. Predictions in both cohorts were tested using receiver operating characteristic curves (ROC). The best model to predict lost to follow-up outcome included the following characteristics: immigration (1 point value), living alone (1 point) or in an institution (2 points), previous anti-TB treatment (2 points), poor patient understanding (2 points), intravenous drugs use (IDU) (4 points) or unknown IDU status (1 point). Scores of 0, 1, 2, 3, 4 and 5 points were associated with a lost to follow-up probability of 2,2% 5,4% 9,9%, 16,4%, 15%, and 28%, respectively. The ROC curve for the validation group demonstrated a good fit (AUC: 0,67 [95% CI; 0,65-0,70]). This model has a good capacity to predict a lost to follow-up outcome. Its use could help TB Programs to determine which patients are good candidates for DOT and other strategies to improve TB treatment adherence.
doi_str_mv 10.1186/1465-9921-13-75
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_978466812d3e47d8be9e17372b6bba3b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534239249</galeid><doaj_id>oai_doaj_org_article_978466812d3e47d8be9e17372b6bba3b</doaj_id><sourcerecordid>A534239249</sourcerecordid><originalsourceid>FETCH-LOGICAL-b646t-bea21475a782c0445a94f137dc418dd60913a6cc22a210cf41ab0ed24fe6844a3</originalsourceid><addsrcrecordid>eNqFktuL1DAUh4so7kWffZOCL750N7fm8iKMi6srC74o-BaS9HTM0DZjkq7435s64-jIihTacM6Xj_T8UlXPMLrAWPJLzHjbKEVwg2kj2gfV6b5CPz88rAk-qc5S2iCEhRTt4-qEEEUlYui0er-qtxE677K_gzq5EP20rv2UcpxHmHLdh1jn2UJ08xCST3V55zqH0hiG8K2Zt3WYswsjPKke9WZI8HT_Pa8-Xb_5ePWuuf3w9uZqddtYznhuLBiCmWiNkMQhxlqjWI-p6BzDsus4Upga7hwhhUOuZ9hYBB1hPXDJmKHn1c3O2wWz0dvoRxO_62C8_lkIca1NzN4NoJWQjHOJSUeBiU5aUIAFFcRyaw21xfVq59rOdoTOlT-OZjiSHncm_0Wvw52mTCElRRG83gmsD_8QHHfKpPSSi15y0Zhq0RbJy_0pYvg6Q8p69MnBMJgJwpwKxSSTJW_8fxQzKiVXihf0xV_oJsxxKtEUisqWCiTUb2ptysD81IdyTLdI9aqljFBF2EJd3EOVp4PRuzBB70v9aMPlboOLIaUI_WEkGOnl6t4zhOd_RnHgf91V-gMvIugO</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1138537079</pqid></control><display><type>article</type><title>A predictive scoring instrument for tuberculosis lost to follow-up outcome</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Rodrigo, Teresa ; Caylà, Joan A ; Casals, Martí ; García-García, José M ; Caminero, José A ; Ruiz-Manzano, Juan ; Blanquer, Rafael ; Vidal, Rafael ; Altet, Neus ; Calpe, José L ; Penas, Antón</creator><creatorcontrib>Rodrigo, Teresa ; Caylà, Joan A ; Casals, Martí ; García-García, José M ; Caminero, José A ; Ruiz-Manzano, Juan ; Blanquer, Rafael ; Vidal, Rafael ; Altet, Neus ; Calpe, José L ; Penas, Antón ; Working Group on Completion of Tuberculosis Treatment in Spain ; Working Group on Completion of Tuberculosis Treatment in Spain</creatorcontrib><description>Adherence to tuberculosis (TB) treatment is troublesome, due to long therapy duration, quick therapeutic response which allows the patient to disregard about the rest of their treatment and the lack of motivation on behalf of the patient for improved. The objective of this study was to develop and validate a scoring system to predict the probability of lost to follow-up outcome in TB patients as a way to identify patients suitable for directly observed treatments (DOT) and other interventions to improve adherence. Two prospective cohorts, were used to develop and validate a logistic regression model. A scoring system was constructed, based on the coefficients of factors associated with a lost to follow-up outcome. The probability of lost to follow-up outcome associated with each score was calculated. Predictions in both cohorts were tested using receiver operating characteristic curves (ROC). The best model to predict lost to follow-up outcome included the following characteristics: immigration (1 point value), living alone (1 point) or in an institution (2 points), previous anti-TB treatment (2 points), poor patient understanding (2 points), intravenous drugs use (IDU) (4 points) or unknown IDU status (1 point). Scores of 0, 1, 2, 3, 4 and 5 points were associated with a lost to follow-up probability of 2,2% 5,4% 9,9%, 16,4%, 15%, and 28%, respectively. The ROC curve for the validation group demonstrated a good fit (AUC: 0,67 [95% CI; 0,65-0,70]). This model has a good capacity to predict a lost to follow-up outcome. Its use could help TB Programs to determine which patients are good candidates for DOT and other strategies to improve TB treatment adherence.</description><identifier>ISSN: 1465-9921</identifier><identifier>ISSN: 1465-993X</identifier><identifier>EISSN: 1465-993X</identifier><identifier>EISSN: 1465-9921</identifier><identifier>DOI: 10.1186/1465-9921-13-75</identifier><identifier>PMID: 22938040</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adherence ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Algorithms ; Analysis ; Care and treatment ; Confidence intervals ; Emigration and Immigration - statistics &amp; numerical data ; Epidemiology ; Female ; Health aspects ; Hospitals ; Humans ; International organizations ; Lost to Follow-Up ; Lost to follow-up outcome ; Male ; Marital Status - statistics &amp; numerical data ; Middle Aged ; Mycobacterium ; Outcome and process assessment (Health Care) ; Patient compliance ; Patient Compliance - statistics &amp; numerical data ; Patient outcomes ; Patient Selection ; Predictors ; Prognosis ; Scoring system ; Spain - epidemiology ; Tuberculosis ; Tuberculosis - drug therapy ; Tuberculosis - epidemiology ; Young Adult</subject><ispartof>Respiratory research, 2012-09, Vol.13 (1), p.75-75</ispartof><rights>COPYRIGHT 2012 BioMed Central Ltd.</rights><rights>2012 Rodrigo et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2012 Rodrigo et al.; licensee BioMed Central Ltd. 2012 Rodrigo et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b646t-bea21475a782c0445a94f137dc418dd60913a6cc22a210cf41ab0ed24fe6844a3</citedby><cites>FETCH-LOGICAL-b646t-bea21475a782c0445a94f137dc418dd60913a6cc22a210cf41ab0ed24fe6844a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490987/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1138537079?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25744,27915,27916,37003,37004,44581,53782,53784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22938040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodrigo, Teresa</creatorcontrib><creatorcontrib>Caylà, Joan A</creatorcontrib><creatorcontrib>Casals, Martí</creatorcontrib><creatorcontrib>García-García, José M</creatorcontrib><creatorcontrib>Caminero, José A</creatorcontrib><creatorcontrib>Ruiz-Manzano, Juan</creatorcontrib><creatorcontrib>Blanquer, Rafael</creatorcontrib><creatorcontrib>Vidal, Rafael</creatorcontrib><creatorcontrib>Altet, Neus</creatorcontrib><creatorcontrib>Calpe, José L</creatorcontrib><creatorcontrib>Penas, Antón</creatorcontrib><creatorcontrib>Working Group on Completion of Tuberculosis Treatment in Spain</creatorcontrib><creatorcontrib>Working Group on Completion of Tuberculosis Treatment in Spain</creatorcontrib><title>A predictive scoring instrument for tuberculosis lost to follow-up outcome</title><title>Respiratory research</title><addtitle>Respir Res</addtitle><description>Adherence to tuberculosis (TB) treatment is troublesome, due to long therapy duration, quick therapeutic response which allows the patient to disregard about the rest of their treatment and the lack of motivation on behalf of the patient for improved. The objective of this study was to develop and validate a scoring system to predict the probability of lost to follow-up outcome in TB patients as a way to identify patients suitable for directly observed treatments (DOT) and other interventions to improve adherence. Two prospective cohorts, were used to develop and validate a logistic regression model. A scoring system was constructed, based on the coefficients of factors associated with a lost to follow-up outcome. The probability of lost to follow-up outcome associated with each score was calculated. Predictions in both cohorts were tested using receiver operating characteristic curves (ROC). The best model to predict lost to follow-up outcome included the following characteristics: immigration (1 point value), living alone (1 point) or in an institution (2 points), previous anti-TB treatment (2 points), poor patient understanding (2 points), intravenous drugs use (IDU) (4 points) or unknown IDU status (1 point). Scores of 0, 1, 2, 3, 4 and 5 points were associated with a lost to follow-up probability of 2,2% 5,4% 9,9%, 16,4%, 15%, and 28%, respectively. The ROC curve for the validation group demonstrated a good fit (AUC: 0,67 [95% CI; 0,65-0,70]). This model has a good capacity to predict a lost to follow-up outcome. Its use could help TB Programs to determine which patients are good candidates for DOT and other strategies to improve TB treatment adherence.</description><subject>Adherence</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Algorithms</subject><subject>Analysis</subject><subject>Care and treatment</subject><subject>Confidence intervals</subject><subject>Emigration and Immigration - statistics &amp; numerical data</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>Humans</subject><subject>International organizations</subject><subject>Lost to Follow-Up</subject><subject>Lost to follow-up outcome</subject><subject>Male</subject><subject>Marital Status - statistics &amp; numerical data</subject><subject>Middle Aged</subject><subject>Mycobacterium</subject><subject>Outcome and process assessment (Health Care)</subject><subject>Patient compliance</subject><subject>Patient Compliance - statistics &amp; numerical data</subject><subject>Patient outcomes</subject><subject>Patient Selection</subject><subject>Predictors</subject><subject>Prognosis</subject><subject>Scoring system</subject><subject>Spain - epidemiology</subject><subject>Tuberculosis</subject><subject>Tuberculosis - drug therapy</subject><subject>Tuberculosis - epidemiology</subject><subject>Young Adult</subject><issn>1465-9921</issn><issn>1465-993X</issn><issn>1465-993X</issn><issn>1465-9921</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFktuL1DAUh4so7kWffZOCL750N7fm8iKMi6srC74o-BaS9HTM0DZjkq7435s64-jIihTacM6Xj_T8UlXPMLrAWPJLzHjbKEVwg2kj2gfV6b5CPz88rAk-qc5S2iCEhRTt4-qEEEUlYui0er-qtxE677K_gzq5EP20rv2UcpxHmHLdh1jn2UJ08xCST3V55zqH0hiG8K2Zt3WYswsjPKke9WZI8HT_Pa8-Xb_5ePWuuf3w9uZqddtYznhuLBiCmWiNkMQhxlqjWI-p6BzDsus4Upga7hwhhUOuZ9hYBB1hPXDJmKHn1c3O2wWz0dvoRxO_62C8_lkIca1NzN4NoJWQjHOJSUeBiU5aUIAFFcRyaw21xfVq59rOdoTOlT-OZjiSHncm_0Wvw52mTCElRRG83gmsD_8QHHfKpPSSi15y0Zhq0RbJy_0pYvg6Q8p69MnBMJgJwpwKxSSTJW_8fxQzKiVXihf0xV_oJsxxKtEUisqWCiTUb2ptysD81IdyTLdI9aqljFBF2EJd3EOVp4PRuzBB70v9aMPlboOLIaUI_WEkGOnl6t4zhOd_RnHgf91V-gMvIugO</recordid><startdate>20120902</startdate><enddate>20120902</enddate><creator>Rodrigo, Teresa</creator><creator>Caylà, Joan A</creator><creator>Casals, Martí</creator><creator>García-García, José M</creator><creator>Caminero, José A</creator><creator>Ruiz-Manzano, Juan</creator><creator>Blanquer, Rafael</creator><creator>Vidal, Rafael</creator><creator>Altet, Neus</creator><creator>Calpe, José L</creator><creator>Penas, Antón</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20120902</creationdate><title>A predictive scoring instrument for tuberculosis lost to follow-up outcome</title><author>Rodrigo, Teresa ; Caylà, Joan A ; Casals, Martí ; García-García, José M ; Caminero, José A ; Ruiz-Manzano, Juan ; Blanquer, Rafael ; Vidal, Rafael ; Altet, Neus ; Calpe, José L ; Penas, Antón</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b646t-bea21475a782c0445a94f137dc418dd60913a6cc22a210cf41ab0ed24fe6844a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adherence</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Algorithms</topic><topic>Analysis</topic><topic>Care and treatment</topic><topic>Confidence intervals</topic><topic>Emigration and Immigration - statistics &amp; numerical data</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>Humans</topic><topic>International organizations</topic><topic>Lost to Follow-Up</topic><topic>Lost to follow-up outcome</topic><topic>Male</topic><topic>Marital Status - statistics &amp; numerical data</topic><topic>Middle Aged</topic><topic>Mycobacterium</topic><topic>Outcome and process assessment (Health Care)</topic><topic>Patient compliance</topic><topic>Patient Compliance - statistics &amp; numerical data</topic><topic>Patient outcomes</topic><topic>Patient Selection</topic><topic>Predictors</topic><topic>Prognosis</topic><topic>Scoring system</topic><topic>Spain - epidemiology</topic><topic>Tuberculosis</topic><topic>Tuberculosis - drug therapy</topic><topic>Tuberculosis - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodrigo, Teresa</creatorcontrib><creatorcontrib>Caylà, Joan A</creatorcontrib><creatorcontrib>Casals, Martí</creatorcontrib><creatorcontrib>García-García, José M</creatorcontrib><creatorcontrib>Caminero, José A</creatorcontrib><creatorcontrib>Ruiz-Manzano, Juan</creatorcontrib><creatorcontrib>Blanquer, Rafael</creatorcontrib><creatorcontrib>Vidal, Rafael</creatorcontrib><creatorcontrib>Altet, Neus</creatorcontrib><creatorcontrib>Calpe, José L</creatorcontrib><creatorcontrib>Penas, Antón</creatorcontrib><creatorcontrib>Working Group on Completion of Tuberculosis Treatment in Spain</creatorcontrib><creatorcontrib>Working Group on Completion of Tuberculosis Treatment in Spain</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Respiratory research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodrigo, Teresa</au><au>Caylà, Joan A</au><au>Casals, Martí</au><au>García-García, José M</au><au>Caminero, José A</au><au>Ruiz-Manzano, Juan</au><au>Blanquer, Rafael</au><au>Vidal, Rafael</au><au>Altet, Neus</au><au>Calpe, José L</au><au>Penas, Antón</au><aucorp>Working Group on Completion of Tuberculosis Treatment in Spain</aucorp><aucorp>Working Group on Completion of Tuberculosis Treatment in Spain</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A predictive scoring instrument for tuberculosis lost to follow-up outcome</atitle><jtitle>Respiratory research</jtitle><addtitle>Respir Res</addtitle><date>2012-09-02</date><risdate>2012</risdate><volume>13</volume><issue>1</issue><spage>75</spage><epage>75</epage><pages>75-75</pages><issn>1465-9921</issn><issn>1465-993X</issn><eissn>1465-993X</eissn><eissn>1465-9921</eissn><abstract>Adherence to tuberculosis (TB) treatment is troublesome, due to long therapy duration, quick therapeutic response which allows the patient to disregard about the rest of their treatment and the lack of motivation on behalf of the patient for improved. The objective of this study was to develop and validate a scoring system to predict the probability of lost to follow-up outcome in TB patients as a way to identify patients suitable for directly observed treatments (DOT) and other interventions to improve adherence. Two prospective cohorts, were used to develop and validate a logistic regression model. A scoring system was constructed, based on the coefficients of factors associated with a lost to follow-up outcome. The probability of lost to follow-up outcome associated with each score was calculated. Predictions in both cohorts were tested using receiver operating characteristic curves (ROC). The best model to predict lost to follow-up outcome included the following characteristics: immigration (1 point value), living alone (1 point) or in an institution (2 points), previous anti-TB treatment (2 points), poor patient understanding (2 points), intravenous drugs use (IDU) (4 points) or unknown IDU status (1 point). Scores of 0, 1, 2, 3, 4 and 5 points were associated with a lost to follow-up probability of 2,2% 5,4% 9,9%, 16,4%, 15%, and 28%, respectively. The ROC curve for the validation group demonstrated a good fit (AUC: 0,67 [95% CI; 0,65-0,70]). This model has a good capacity to predict a lost to follow-up outcome. Its use could help TB Programs to determine which patients are good candidates for DOT and other strategies to improve TB treatment adherence.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>22938040</pmid><doi>10.1186/1465-9921-13-75</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1465-9921
ispartof Respiratory research, 2012-09, Vol.13 (1), p.75-75
issn 1465-9921
1465-993X
1465-993X
1465-9921
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_978466812d3e47d8be9e17372b6bba3b
source Publicly Available Content (ProQuest); PubMed Central; EZB Electronic Journals Library
subjects Adherence
Adolescent
Adult
Aged
Aged, 80 and over
Algorithms
Analysis
Care and treatment
Confidence intervals
Emigration and Immigration - statistics & numerical data
Epidemiology
Female
Health aspects
Hospitals
Humans
International organizations
Lost to Follow-Up
Lost to follow-up outcome
Male
Marital Status - statistics & numerical data
Middle Aged
Mycobacterium
Outcome and process assessment (Health Care)
Patient compliance
Patient Compliance - statistics & numerical data
Patient outcomes
Patient Selection
Predictors
Prognosis
Scoring system
Spain - epidemiology
Tuberculosis
Tuberculosis - drug therapy
Tuberculosis - epidemiology
Young Adult
title A predictive scoring instrument for tuberculosis lost to follow-up outcome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T23%3A39%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20predictive%20scoring%20instrument%20for%20tuberculosis%20lost%20to%20follow-up%20outcome&rft.jtitle=Respiratory%20research&rft.au=Rodrigo,%20Teresa&rft.aucorp=Working%20Group%20on%20Completion%20of%20Tuberculosis%20Treatment%20in%20Spain&rft.date=2012-09-02&rft.volume=13&rft.issue=1&rft.spage=75&rft.epage=75&rft.pages=75-75&rft.issn=1465-9921&rft.eissn=1465-993X&rft_id=info:doi/10.1186/1465-9921-13-75&rft_dat=%3Cgale_doaj_%3EA534239249%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b646t-bea21475a782c0445a94f137dc418dd60913a6cc22a210cf41ab0ed24fe6844a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1138537079&rft_id=info:pmid/22938040&rft_galeid=A534239249&rfr_iscdi=true